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Objective(s): Various studies have shown that the diabetes is associated with liver failure. The 
objective of this study was determining the effects of Berberis vulgaris fruit on histopathological and 
biochemical markers of liver in diabetic rats. 
Materials and Methods: In this experimental study, 60 male Wistar rats weighing 200-250 g with free 
access to water and ad libitum were randomly divided to five twelve-membered groups including 
healthy control (group 1), diabetic control (group 2, this two groups received distilled water), treated 
diabetic positive control (group 3) using dose 150 mg/kg/day metformin, and two groups treated with 
doses 200 (group 4) and 600 (group 5) mg/kg/BW of B. vulgaris extracts via gavage feeding for 8 
weeks. Diabetes mellitus was experimentally induced by one dose injection of alloxan 120 mg/kg. This 
pre-clinical study was performed on 120 mg/kg alloxan induced diabetic rats.  
Results: The hepatic steatosis status, liver cholestasis and fibrosis were not changed in group 4 and 5. 
Glycogen deposition changed mildly and polymorphonuclear neutrophils infiltration changed 
moderately at group 5. Liver hepatitis changed mildly and severely at group 3 as well as group 5, 
respectively. Glucose, serum glutamic-oxaloacetic transaminase, serum glutamic pyruvic transaminase, 
and alkaline phosphatase were lower in high dose group compared to other groups.  
Conclusion: Results suggested that B. vulgaris extract can decrease liver damage by influencing hepatic 
histopathological and biochemical markers in diabetic rats. 
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Introduction 
 Diabetes mellitus is a common metabolic disease 
that its prevalence is 6.4 percent worldwide. It is 
estimated that more than 280 million people have 
diabetes and it is predicted that over 330 million 
people will be affected by 2025. Diabetes has several 
complications such as retinopathy, neuropathy, and 
nephropathy (1-4).  
A number of studies have shown that the diabetes is 
associated with fibrosis liver disease, non alcoholic fatty 
liver disease (NAFLD), as well as cirrhosis and 
hepatocellular carcinoma (HCC). These and some other 
complications of diabetes cause significant morbidity. 
Various chemical drugs are used to treat or control the 
diabetes; however, they are associated with side effects. 
For example, sulfonylurea drugs cause weight gain due 
to hyper-insulinemia, biguanides cause weakness, 
fatigue, lactic acidosis, alpha-glucosidase inhibitors may 
cause diarrhea while thiazolidinediones may increase  
 
low density lipoprotein (LDL) and cholesterol levels. 
Alternative therapy for diabetes (5-7) and some other  
hard curable diseases (8-10). Plants as an alternative 
are potential source of hypoglycemic drugs, which can 
manage diabetes more efficiently and safely and are 
widely used in traditional systems of medicine to 
prevent or treat diabetes (11-13).  
It is well known that Berberis vulgaris fruit can cause 
hypoglycemia and it has cytoprotective effect on 
hepatocytes. B. vulgaris is a shrub in the family 
Berberidaceae. Previous studies have shown that B. 
vulgaris can inhibit intestinal ion secretion, smooth 
muscle contraction, ventricular tachyarrhythmia, and 
inflammation (14). These results suggested that  
methanol extract of Berberis family such as tinctoria and 
vulgaris/β-cyclodextrin may have potential therapeutic 
value in the treatment of the liver disorders and also 
hepatic injury induced by CCl4 via its antioxidative effect 
on hepatocytes (15, 16).  
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Furthermore, study of Girish et al showed that 
polyherbal liquid formulations (PLFs) can prevent 
acute liver damage induced by CCl4 only at a higher 
dose; therefore, it is suggested that a dose adjustment 
of these PLFs may be necessary for their optimal effects 
in human liver diseases (17). 
Upwar et al in 2011 reported that methanolic 
extract of Berberis aristata significantly reduced the 
blood glucose, total cholesterol and triglycerides, and 
also increasing the HDL cholesterol level in diabetic 
rats; so this extract have very hypoglycemic as well as 
hypolipidemic activities (18). Results from the Meliani 
et al study demonstrated significant antidiabetic effects 
of the aqueous extract of B. vulgaris that declined 
significantly biochemical parameters such as blood 
glucose levels compared to diabetic controls. This 
researchers also showed that serum cholesterol and 
serum triglycerides levels were decreased, therefore  
consequently this plant might be of value in diabetes 
treatment (19). Thus, it has been also recommended for 
a number of other diseases like obesity, hyperlipidemia, 
metabolic syndrome, cholecytitis, and coronary artery 
disease. Despite the natives’ beliefs in the effects of B. 
vulgaris, few investigations have been performed on 
this species. Therefore, the present study was carried 
out with the aim of determining the effects of ethanolic 
extract of B. vulgaris on histopathological changes and 
biochemical markers of liver damage in diabetic rats. 
 
Materials and Methods 
Plant collection and extraction 
B. vulgaris fruit purchased from a reputable 
herbal grocery, was evaluated by a plant biologist 
and recorded at herbarium unit of Medical Plants 
Research Center of Shahrekord University of Medical 
Sciences (Shahrekord, Iran) with the accession Code 
419. Aqueous ethanol (70:30) extract of Berberis 
fruit was prepared using cold maceration process. 
The grounded plant material (2 kg) was soaked in                 
5 l of water-ethanol mixture (70:30) for 72 hr at 
room temperature. After three days of occasional 
shaking, the whole material was filtered and the 
filtrate evaporated under reduced pressure using 
rotary evaporator. The contents were filtered and 
the solvent was isolated by a Rotary concentrator at 
37°C (IKA®RV 10 digital). The concentrated solution 
was incubated at 37°C until it was dried. The crude 
extract was then air-dried to obtain a solid mass. The 
yield of extract was 30%. Then, the obtained solution 
was collected from containers and  kept in the 
refrigerator at 4 °C. 
 
Experimental design 
In this pre-clinical study, 60 Wistar rats were 
purchased from the Iran Pasteur institute with a 
weight range of 250±25 g, and were kept in the 
animal house of Shahrekord University of Medical 
Sciences for seven days for acclimatization. The 
temperature of animals' house was   22± 2 °C with12 
hr of light and 12 hr of darkness. Briefly, 60 male 
Wistar rats weighing 200-250 g with free access to 
water and ad libitum were randomly divided to five 
twelve-membered groups including healthy control 
(group 1), diabetic control (group 2; these two 
groups received distilled water), treated diabetic 
positive control (group 3) using dose 150 mg/kg/day 
metformin, and two groups treated with doses 200 
(group 4) and 600 (group 5) mg/kg/BW of B. 
vulgaris extracts via gavage feeding for 8 weeks.  
Experimental diabetes was induced by a single 
intraperitoneal injection (IP) with 120 mg/kg alloxan 
(Sigma Chemical Company, USA) in all groups except 
healthy control group (20). Animals were deprived 
of food for 12 hr before alloxan injection. This study 
was approved by the ethics committee of the medical 
university of Shahrekord (Code: 91-12-6). 
 
Biochemical assays 
At the end of eight weeks, the animals were 
anesthetized with chloroform, and then blood 
samples were taken by cardiac puncture for 
biochemical analysis. Blood was collected in a dry 
test tube and allowed to coagulate at ambient 
temperature for 30 min. Serum was separated by 
centrifugation at 2000 rpm for 10 min for the 
estimation of serum glutamic pyruvic transaminase 
(SGPT), serum glutamic-oxaloacetic transaminase 
(SGOT), and alkaline phosphatase (ALP) and glucose 
(21, 22). ALP was determined by enzymatic assays. 
SGOT and SGPT activities were determined by the 
methods introduced previously (21, 23).  
 
Histopathological examination 
The liver was removed and fixed in 10% formalin 
solution for histopathological testes. Then it was 
embedded in paraffin, and stained with Hematoxylin–
Eosin. Glycogen deposition, fat deposition (steatosis), 
hepatic polymorphonuclear neutrophil (PMN) 
infiltration, inflammation in the liver parenchyma 
(Hepatitis), accumulation of bile pigments (cholestasis) 
and fibrosis in the liver parenchyma (fibrosis) were 
assessed (24). 
 
Statistical analysis 
The Mean±SD was used for descriptive statistics. 
For each variable, the normal distribution was 
evaluated and confirmed using the one-sample 
Kolmogorov test. The ANOVA test was used for 
comparing the variables between groups and LSD test 
was used for pairwise comparisons. Statistical 
significance was defined as P<0.05 and analysis was 
done using SPSS  ) Version 11; SPSS Inc., Chicago, USA(. 
 
Results  
Histopathological observations of liver 
The histological assessment of liver tissue of 
control and treated rats with B. vulgaris showed mild 
change in glycogen deposition at group 5 at the end 
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of the study, however, no change was seen in other 
groups. Hepatic steatosis status was not changed at 
any group. Hepatic polymorphonuclear neutrophils 
(PMN) infiltration changed moderately at group 5  
but there was no change in other groups. Liver 
hepatitis changed mildly and severally at diabetic 
positive control group and group 5, respectively. 
Liver cholestasis and fibrosis were not changed at 
any group (Table 1). 
 
Liver biochemical parameter 
As shown in Table 2, the amount of glucose in group 
4 was significantly higher than healthy control group and 
group 5, while the amount of glucose in the group 5 was 
significantly lower compared to diabetic control, the 
positive diabetic control and the group 4. The amount of 
Serum glutamic oxalacetic transaminase (SGOT) was 
significantly higher in the group 4 compared to the 
healthy controls, the positive diabetic control and group 
5, but it was lower in the group 5 comparing to all 
groups. The amount of serum glutamic pyruvic 
transaminase (SGPT) was significantly higher in the 
group 4 than the healthy control and group 5 while it 
was lower in group 5 than the positive diabetic control. 
The alkaline phosphatase (ALP) amount was 
significantly higher in group 4 compared to the healthy  
control group and it in group 5 was significantly lower 
than diabetic control.    
 
Discussion 
An initial objective of this project was to identify the 
effects of ethanol extract of B. vulgaris on 
histopathological changes of the liver in diabetic rats. The 
current study found that hepatic steatosis status, liver 
cholestasis and fibrosis didn’t change at any group. 
Glycogen deposition changed mildly and PMN infiltration 
changed moderately at group 5. Liver hepatitis changed 
mildly and severally at diabetic positive control group 
and group 5 respectively. These results match those 
observed in earlier studies such as Othman et al (25) that 
berberine (an isoquinoline alkaloid extracted from                      
the barks and roots of several species of the berberis), 
increased antioxidant protection against HgCl2 -induced 
toxicity and it may have hepato- and reno-protective 
effect. Hermenean et al have demonstrated                         
that B. vulgaris/β-cyclodextrin prevented CCl4 induced 
hepatic injury (26). Also in another study performed in 
diabetic rats it was established that administration of 
Berberis integerrima Bge root before diabetes induction 
ameliorated liver complications. In another study 
berberine could protect hepatic tissue destruction (27). 
 
 
 
 
 
 
 
 
Table 1. Effects of ethanol extract of B. vulgaris on liver histopathological changes at the end of study 
 
Fibrosis Cholestasis Hepatitis PMN infiltration Steatosis Glycogen depositon Groups 
Neg Neg Neg Neg Neg Neg Healthy control (1) 
Neg Neg Neg Neg Neg Neg Diab. Control (2) 
Neg Neg Pos+ Neg Neg Neg Diab. Metformin (3) 
Neg Neg Neg Neg Neg Neg Diab. B. vulgaris 200 (4) 
Neg Neg Pos ++ Pos + Neg Neg / Pos Diab. B. vulgaris 600 (5) 
 
Diab.: Diabetic; B. vulgaris: Extract of  Berberis vulgaris  
Healthy and diabetic groups received normal food; Diabetic positive control group received normal food and 150 mg/kg/day metformin; 
Diab. B. vulgaris received 200 mg/kg/day and Diab. B. vulgaris received 600 mg/kg of B. vulgaris. 
Pos.= positive; Neg.= negative; Neg/pos= mild change; Pos += moderate change; Pos ++= sever change 
 
 
 
 
 
 
Table 2. Effects of ethanol extract of B. vulgaris on biochemical parameters at the end of study 
 
 
Groups 
variable 
Healthy Control 
(1) 
Diab. Control 
(2) 
Diab. Metformin 
(3) 
Diab. B. vulgaris  
200 mg/kg (4) 
Diab. B. vulgaris 
 600 mg/kg (5) 
P value 
Glucose 
(Mg/dl) 
106.5±8.7 
•*ab 
526.4±19.3 
†b 
528.8±20.3 
†b 
514.1±12.5 
†b 
404.6±30.9 
•*†a 
P≤0.05 
SGOT 
(U/l) 
138.9±9.3 
•*ab 
223.6±13.6 
†b 
206.3±8.2 
*†ab 
220.6±17.9 
•†b 
169.5±9.4 
•*†a 
P≤0.05 
SGPT 
(U/l) 
64.6±6.3 
•*ab 
97.5±10.8 
† 
107.0±14.3 
†b 
104.0±10.7 
†b 
88.3±7.9 
•† 
P≤0.05 
ALP (U/l) 
356.4±34.9 
•*ab 
512.6±36.6 
†b 
489.1±46.7 
† 
471.1±26.7 
† 
450.4±24.0 
*† 
P≤0.05 
 
 
Diab.: Diabetic; B. vulgaris: Extract of Berberis vulgaris; SGOT: Serum glutamic oxalacetic transaminase; SGPT: serum glutamic pyruvic 
transaminase; ALP: alkaline phosphatase and: All results are reported as mean ± standard deviation; P<0.05 was considered statistically 
significant 
†: significant compared with the healthy control group, * : significant compared with the diabetic control group, • : significant compared 
with the diabetic metformin, a: significant compared with the diabetic B. vulgaris received 200 mg/kg and  b: significant compared with             
B. vulgaris received 600 mg/kg 
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This study sought to determine the effects of red 
Berberis on the biochemical liver markers. The result of 
the study showed glucose, SGOT, SGPT and ALP were 
lower in group 5 compared to other groups. These 
results confirmed previous study in which the levels of 
SGPT, SGOT, ALP, total proteins, and serum bilirubin 
decreased in treated animals with the methanol extract 
of Berberis tinctoria (28). While lowering blood sugar, 
Barberry higher doses (600 mg/kg), had protective 
effects on the liver. According to previous study the 
berberis have not side effects or cytotoxicity on animal 
diabetes models(29). A possible explanation for these 
results may be the composition of Barberries. Barberries 
contain organic acids and phenolic compounds such as 
anthocyanin and carotenoid pigments as well as 
polyphenolase, phenolase, glycosidase enzymes, and the 
different alkaloids with an isoquinolinic nucleus such as 
berbamine, berberine, and palmatine existing in the 
different parts of this plant. These constituents have 
antioxidant effects due to their interaction with various 
molecules. It should be noted that antioxidants have 
previously confirmed to be effective not only in liver 
toxicity, but also in a number of other diseases such as 
kidney disease (30-32) hypertension (33) cancer (34, 
35), and infectious diseases (36, 37). In regard to 
mentioned results, further researches seem necessary to 
further investigate the effects of this plant in humans. 
Considering the increasing preclinical studies, berberis 
seems to be of benefits for both type I and type II 
diabetes patients (15, 38, 39).   
 
Conclusion  
The present study was designed to determine the 
effects of B. vulgaris on histopathological and 
biochemical markers of the liver in diabetic rats. This 
research on hepatic histopathological and biochemical 
markers showed that this plant could delay and 
moderate liver damage. An implication is the possibility 
that B. vulgaris might be effective on liver damage in 
humans as well. 
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